Oral News and Research

RSS

Bacteriophage combinations show therapeutic potential in reducing C. difficile infections

A new University of Leicester study has confirmed the therapeutic potential of bacteriophage combinations to treat highly infectious bacteria C. difficile infections (CDI) while retaining a healthy gut.

6 Jun 2016

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.

6 Jun 2016

New research reveals advances that could change gynecologic cancer standard-of-care treatments

Advances that could change gynecologic cancer standard-of-care treatments are the centerpiece of key studies being presented by researchers from The University of Texas MD Anderson Cancer Center's Department of Gynecologic Oncology and Reproductive Medicine at the 2016 Annual Meeting of the American Society of Clinical Oncology.

6 Jun 2016

CMR could offer complete imaging solution before pulmonary vein isolation

Cardiac magnetic resonance can potentially be used to detect thrombi at the same time as being used for pulmonary venous anatomy mapping, say researchers

4 Jun 2016

BetterYou’s DLuxPregnancy daily vitamin D oral spray offers more effective solution than tablets for expectant mums

A simple daily oral vitamin D spray by health pioneers BetterYou, can offer a more effective solution than tablets for expectant mums urged to boost vitamin D and folic acid levels.

From BetterYou Ltd 3 Jun 2016

Retroviral replicating vector can extend lives of brain cancer patients

Doctors at UCLA, Cleveland Clinic, University of California San Diego School of Medicine and additional institutions have achieved a milestone in the development of a treatment for people with recurrent glioblastoma, the most common and aggressive form of brain cancer, by successfully demonstrating a modified virus that can extend the lives of patients with the disease.

2 Jun 2016

Scientists examine how common beverages affect people's hydration levels

Scientists at the universities of Stirling, Loughborough and Bangor are calling for the creation of a beverage hydration index to help people understand how different drinks can keep you hydrated.

2 Jun 2016

Dr Anjali Mahto explains how to prevent risk of mosquito bites

Nobody likes being bitten by mosquitos whether it’s at home or abroad. Consultant Dermatologist & British Skin Foundation spokesperson, Dr Anjali Mahto explains how to deter the summer pests, what to do when bitten and why they are attracted to us in the first place.

2 Jun 2016

New NPS MedicineWise program aims to help health professionals improve diabetes management

A new educational program aims to help health professionals keep up to date with the latest evidence on second and third line medicines for lowering blood glucose.

2 Jun 2016

Just one stroke risk factor signals anticoagulation need in AF

The risk of stroke or systemic embolism is significantly increased in atrial fibrillation patients with just one risk factor apart from gender, say researchers.

2 Jun 2016

Clinical trial to test safety, efficacy of Roswell Park-developed SurVaxM in multiple myeloma patients

An immune-based therapy developed at Roswell Park Cancer Institute is moving forward with its third clinical trial. The early-stage clinical trial will assess whether SurVaxM — a cancer vaccine developed at Roswell Park — is a safe and effective treatment option for patients with multiple myeloma, a rare type of blood cancer.

1 Jun 2016

Cigarette smoke promotes bacteria colonization, immune invasion

The mouth is one of the "dirtiest" parts of the body, home to millions of germs. But puffing cigarettes can increase the likelihood that certain bacteria like Porphyromonas gingivalis will not only set up camp but will build a fortified city in the mouth and fight against the immune system.

1 Jun 2016

Study identifies persistent opioid use in some patients after knee or hip replacement

Many patients undergoing hip or knee replacement are still taking prescription opioid pain medications up to six months after surgery, reports a study in PAIN, the official publication of the International Association for the Study of Pain.

1 Jun 2016

Betrixaban scores near miss for extended thromboprophylaxis

Extended thromboprophylaxis with the direct factor Xa inhibitor betrixaban just fails to show superiority to standard treatment with enoxaparin in acutely ill medical patients.

1 Jun 2016

Neurological problems can impair sexuality

Neurological disorders can impair sexuality on a much more massive scale than frequently assumed, leaving loss of desire, erection problems and infertility in their wake.

31 May 2016

Obese individuals who consume aspartame may have worse glucose management

Artificial sweeteners help individuals with obesity to cut calories and lose weight but may have negative health effects, according to researchers at York University's Faculty of Health.

25 May 2016

Clinical trials of anti-cancer agent PAC-1 continue to progress with anonymous funding

Clinical trials of the anti-cancer agent PAC-1 are continuing to expand, thanks to a $7 million angel investment from an anonymous contributor who originally invested $4 million to help get the compound this far in the drug-approval pipeline.

25 May 2016

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, and melanoma, according to results from a phase I clinical trial.

23 May 2016

Injectable IPV with bivalent oral vaccine safer than using oral vaccine alone

A groundbreaking study released today shows that a single injectable dose of inactivated polio vaccine (IPV) along with bivalent oral polio vaccine could protect up to 90 percent of children from polio and strengthen community protection against the disease.

23 May 2016

Phase I study of triple drug combination shows promise in multiple myeloma patients

PharmaMar announces the positive results from a Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma.

21 May 2016

Oral News and Research

Bacteriophage combinations show therapeutic potential in reducing C. difficile infections

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

New research reveals advances that could change gynecologic cancer standard-of-care treatments

CMR could offer complete imaging solution before pulmonary vein isolation

BetterYou’s DLuxPregnancy daily vitamin D oral spray offers more effective solution than tablets for expectant mums

Retroviral replicating vector can extend lives of brain cancer patients

Scientists examine how common beverages affect people's hydration levels

Dr Anjali Mahto explains how to prevent risk of mosquito bites

New NPS MedicineWise program aims to help health professionals improve diabetes management

Just one stroke risk factor signals anticoagulation need in AF

Clinical trial to test safety, efficacy of Roswell Park-developed SurVaxM in multiple myeloma patients

Cigarette smoke promotes bacteria colonization, immune invasion

Study identifies persistent opioid use in some patients after knee or hip replacement

Betrixaban scores near miss for extended thromboprophylaxis

Neurological problems can impair sexuality

Obese individuals who consume aspartame may have worse glucose management

Clinical trials of anti-cancer agent PAC-1 continue to progress with anonymous funding

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Injectable IPV with bivalent oral vaccine safer than using oral vaccine alone

Phase I study of triple drug combination shows promise in multiple myeloma patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News